Home/Filings/4/0001127602-23-018765
4//SEC Filing

ABERCROMBIE GEORGE B 4

Accession 0001127602-23-018765

CIK 0000882796other

Filed

Jun 14, 8:00 PM ET

Accepted

Jun 15, 4:28 PM ET

Size

6.9 KB

Accession

0001127602-23-018765

Insider Transaction Report

Form 4
Period: 2023-06-13
Transactions
  • Award

    Common Stock

    2023-06-13+16,74529,611 total
  • Award

    Automatic Stock Option Grant

    2023-06-13+39,07239,072 total
    Exercise: $8.18From: 2024-06-13Exp: 2033-06-13Common Stock (39,072 underlying)
Footnotes (2)
  • [F1]Automatic non-employee director grant of Restricted Stock Units pursuant to the BioCryst Pharmaceuticals, Inc. Non-Employee Director Compensation Policy (the "Director Compensation Policy"), which will vest on the first anniversary of the date of grant.
  • [F2]Automatic non-employee director grant of stock options pursuant to the Director Compensation Policy.

Issuer

BIOCRYST PHARMACEUTICALS INC

CIK 0000882796

Entity typeother

Related Parties

1
  • filerCIK 0001485939

Filing Metadata

Form type
4
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 4:28 PM ET
Size
6.9 KB